CHRISTOPHER VELA: Open Payments
NPI 1366728909 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,965 in 96 payments from 13 companies in 2025. Trend: 2023 $1,848 · 2024 $1,472 · 2025 $2,965
Food & beverage: $2,059Travel & lodging: $810Education: $95
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 10 | $1,280 |
| AstraZeneca Pharmaceuticals LP | 18 | $434 |
| Amgen Inc. | 16 | $205 |
| Actelion Pharmaceuticals US, Inc. | 6 | $198 |
| PFIZER INC. | 12 | $190 |
| Merck Sharp & Dohme LLC | 7 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $139 |
| Alnylam Pharmaceuticals Inc. | 4 | $123 |
| Novo Nordisk Inc | 5 | $90 |
| Medtronic, Inc. | 2 | $56 |
Products named: Barostim Neo System, Repatha, FARXIGA, WAINUA, OPSUMIT, VERQUVO, JARDIANCE, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
